Education

Biography

Dr. Rajendra D. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.

Research Interest

• Neuroimaging
• Psychiatry
• Cognitive neuroscience

Scientific activities

Primary Academic Appointments (India)

Other Academic Appointments

Honors and Awards

1. 1991, B.K. Anand National Research Prize for most outstanding research in physiology and allied sciences, 1991
2. 1991, Best paper award, Annual Conference, Association of Physiologists and Pharmacologists of India, Bangalore.
3. 2002, Solomon Award of Harvard Medical School for being the best young researcher in psychiatry.
4. 2002, Dupont Warren Fellowship. Awarded to the best resident researcher at Harvard Medical School.
5. 2002, Livingston Award. Awarded to the best research project of residents at Harvard Medical School. The award includes research funding.
6. 2004, Best Paper Award, Massachusetts General Hospital Research Day.
7. 2004, Selected as one of the Best Young Investigators in the Annual Meeting of Society of Nuclear Medicine.
8. 2004, Selected Dana Foundation Fellow.
9. 2016, Chair, Session on Functional Neuroimaging and Molecular Imaging; Biomarker in Neuroimaging; Neuropsychiatry and Neuroimaging. 2nd Neurological Disorders Summit, United Scientific Group. Baltimore, MD. 9 September 7-9 2016.
10. 2016, Chair, Keynote session. 2nd Neurological Disorders Summit, United Scientific Group. Baltimore, MD. September 7-9 2016.
11. 2016, Chair, Symposium on Imaging Technology in Drug Screening. BIT’s 14th Annual Congress of International Drug Discovery Science and Technology – 2016; November 16-19, 2016, Nanjing, China.
12. 2016, Keynote speaker, International Conference on Neuroimaging and Interventional Neuroradiology, Vienna, Austria. August 22-23, 2016.
13. 2016, Member, Organizing Committee, International Conference on Neuroimaging and Interventional Neuroradiology, Vienna, Austria. August 22-23, 2016.
14. 2016, Member, Organizing Committee, 2nd International Conference on Autism, Phoenix, Arizona. September 15-16, 2016.
15. 2016, Keynote speaker, 2nd Neurological Disorders Summit, United Scientific Group. Baltimore, MD. September 7-9 2016.
16. 2016, Keynote speaker, 2nd International conference on Reward Deficiency Syndrome, United Scientific Group. Baltimore, MD. October 21-23, 2016.
17. 2016, Member, Organizing Committee, 2nd Neurological Disorders Summit, United Scientific Group. Baltimore, MD. September 7-9 2016.
18. 2016, President of the Conference, 2nd Neurological Disorders Summit, United Scientific Group. Baltimore, MD. September 7-9 2016
19. 2016, Member, Organizing Committee, 2nd International conference on Reward Deficiency Syndrome, United Scientific Group. Baltimore, MD. October 21-23.
20. 2016, Director, Continuing Medical Education. 2nd Neurological Disorders Summit, United Scientific Group. Baltimore, MD. September 7-9 2016.
21. 2016, Member, Scientific Committee, 8th International Symposium of Ayurveda and Health. Organized by University of Connecticut Medical School, Farmington, CT, May 5-6, 2016
22. 2016, Invited speaker, BIT’s 6th Annual World Congress of Molecular and Cell Biology 2016. International Conference Center, Dalian China. April 25-28, 2016.
23. 2015, Co-Chairman, Organizing Committee Inaugural Reward Deficiency Syndrome Summit. Reward deficiency syndrome (RDS) in 21st century: 10 Epigenetics, neurogenetics, neuroimaging tools for therapy and recovery. San Francisco, USA, November 16-18, 2015.
24. 2015, Founding Editor-in-Chief of the Journal of Neuroimaging in Psychiatry and Neurology
25. 2015, Founding Co-Editor-in-Chief of the Journal of Reward Deficiency Syndrome
26. 2015, Program Committee, Third Annual International Conference on Neuroscience and Neurobiology Research (CNN), Bangkok, Thailand, October 26-27, 2015
27. 2015, Co-Chairman, Organizing Committee, Neurological Disorder Summit, San Francisco, July 6-8, 2015.
28. 2014, Invited to deliver Psychiatry Grand Rounds at Virginia Commonwealth University, Richmond VA, May 13, 2014.
29. 2014, Invited to deliver Psychiatry Grand Rounds at Thomas Jefferson University, Philadelphia, May 7, 2014.
30. 2014, Invited speaker, International Conference on Neural Networks, Gdansk, Poland, May 15-17, 2014
31. 2014, Selected member of the steering committee of International Eye Scientific Committee
32. 2014, Special Guest Lecture, Indo-Global Healthcare Summit and Expo 2014, Hyderabad, June 20-22, 2014.
33. 2014, Co-Chairman, Organizing Committee, Third International Conference on Addiction Research & Therapy, Chicago, Aug 4-6, 2014
34. 2014, Keynote speaker, International Conference on Recent Advances in Cognition and Health, Varanasi, India, January 23-25, 2014
35. 2014, Panelist, PATH Conference on Finding Adequate Reward: Dopamine and Brain Health. New York, March 21, 2014
36. 2013, Member, Organizing Committee, 3rd World Congress on Cell Science & Stem Cell Research, Baltimore, November 20-22, 2013.
37. 2013, Organize and Chair an International Symposium on Molecular Imaging of Dopamine in the Annual Meeting on Dopamine Neurotransmission (Dopamine 2013), Alghero, Italy May 2013
38. 2013, Plenary Speaker, 2nd International Conference on Addiction and Therapy, Las Vegas, July 22-24, 2013
39. 2013, Member, Program Committee, Annual International Conference on Neuroscience and Neurobiology Research, Singapore, November 14-16,2013.
40. 2013, Invited to Chair a session in 11th Annual Congress of International Drug 11 Discovery Science & Technology, Therapy, Haikou, China, November 13- 16, 2013
41. 2013, Invited to deliver Psychiatry Grand Rounds in University of Florida,Gainesville, FL, March 1, 2013.
42. 2013, Editor, Journal of Addiction and Prevention
43. 2012, Editor-in-Chief of the journal ‘Neuroscience Research Letters’
44. 2012, Chief Editor of the journal ‘British Journal of Education, Society & Behavioural Science’
45. 2012, Executive Editor of the ‘Journal of Alcoholism and Drug Dependence’
46. 2012, Guest Editor of a special Issue on Dopamine Neurotransmission for ‘Open Journal of Neuroscience’
47. 2011, Editor of the ‘Open Journal of Philosophy’
48. 2011, Keynote Presentation in the Conference on ‘Medicine and Beyond’ at the University of Connecticut Medical Center, Farmington, CT
49. 2011, Guest Editor of a special issue on Neurotransmitter Imaging for ‘Current Medical Imaging and Review’
50. 2010, Selected to represent University at Buffalo in the SUNY Symposium on Neurodegenerative Diseases and Stem Cell Therapeutics, organized by the State University of New York at Stony Brook on March 6, 2010.
51. 2009, Editor of ‘PhilPapers: Conscious and Unconscious Memory’
52. 2009, Keynote address in the 4th International Symposium on Cognition, Stress and Mental Health held on December 14-16, 2009 in Varanasi, India
53. 2007, Keynote Presentation in the 4th International Symposium on Consciousness organized by Mayo Clinic, Rochester, MN held on October 6, 2007
54. 2007, Selected as a Significant Contributor in the Annual Meeting of Society of Nuclear Medicine
55. 2006, Selected as Harvard-MIT Clinical Investigator Fellow
56. 2006, Selected as a Significant Contributor in the Annual Meeting of Society of Nuclear Medicine
57. 2006, Invited to deliver a Special Guest Lecture in the 52nd Annual Conference of the Association of Physiologists and Pharmacologists of India
58. 2005, Invited to deliver KN Udupa Memorial Lecture of Banaras Hindu University, India.
59. 2005, Selected as a Significant Contributor in the Annual Meeting of Society of Nuclear Medicine
60. 2004, Dana Foundation International Fellow. The fellowship along with a research grant is awarded to the most outstanding researcher in selected institutions. I was selected fellow for Harvard University.
61. 2004, Selected as a Significant Contributor in the Annual Meeting of Society of Nuclear Medicine.
62. 2004, Selected as one of the Best Young Investigators in the Annual Meeting of Society of Nuclear Medicine
63. 2002, Dupont Warren Fellowship. Awarded to the best resident researcher at Harvard Medical School.
64. 2002, Livingston Award. Awarded to the best research project of residents at Harvard Medical School. The award includes research funding.
65. 1999, Keynote speech in the Third International Symposium on Cognition, Education and Mental Health, at Banaras Hindu University, Varanasi, India.
66. 1991, Best Paper Award, Association of Physiologists and Pharmacologists of India, Bangalore, India.

Publications

1. Febo, Marcelo; Blum, Kenneth; Badgaiyan, Rajendra D; Baron, David; Thanos Panayotis K; Colon-Perez Luis; Demotrovics, Zsolt; Gold Mark S (2017) Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. Frontiers in Bioscience, Landmark, 22:669-691, January 1, 2017.
2. Kenneth Blum, Lyle Fried, Margaret A Madigan John Giordano, Edward J. Modestino, Bruce Steinberg, David Baron, Michael DeLeon, Thomas McLaughlin, Rajendra D. Badgaiyan (2017) Critical Analysis of White House Anti-Drug Plan. Global Journal of Addiction & Rehabilitation Medicine, 1 (4):555-568.
3. Gold MS, Badgaiyan RD, Blum K (2017). Genetic framing of the opiate/opioid epidemic in native Americans: Is reward deficiency the culprit? Austin Psychiatry 2(1)1006
4. McLaughlin Thomas, David Han, James Nicholson, Bruce Steinberg, Kenneth Blum, Eric R. Braverman, Mona Li, Lyle Fried, Rajendra D. Badgaiyan (In Press). Improvement of long-term memory access with a pro-dopamine regulator in an elderly male: Are we targeting dopamine tone? Psychology Research and Behavior Management.
5. Kenneth Blum, Mark S. Gold, Edward J. Modestino, Marcel Febo, Peter K. Thanos, David Baron, Bruce Steinberg, Lyle Fried, Rajendra D. Badgaiyan (In Press). Buprenorphine and Naloxone combinations and Dopamine. Current Psychopharmacology, 6.
6. Blum Kenneth, Modestino Edward J; Febo Marcelo, Steinberg Bruce; McLaughlin Thomas; Fried Lyle; Baron David; and Badgaiyan Rajendra D. (2017). Lyme and dopaminergic function: Hypothesizing reduced reward deficiency symptomatology by regulating dopamine transmission. Journal of Systems and Integrative Neuroscience, 3(3)1-4.
7. Kenneth Blum, Mark S Gold, Lloyd G. Mitchell, Kareem W. Washington, David Baron, Panayotis K. Thanos, Bruce Steinberg, Edward J Modestino, Rajendra D. Badgaiyan (2017). Global evidence for the key role of the dopamine D2 receptor gene (DRD2) and DRD2 receptors in Alcoholism. Journal of Neurogenetics and Research, 1(1)1001
8. Kenneth Blum, B. William Downs, Lyle Fried, David Siwicki, David Baron, Rajendra D. Badgaiyan (In Press). Customized DNA (Precision Medicine) Directed Nutrition to Balance the Brain Reward Circuitry and Reduce Addictive Behaviors. Jacobs Journal of Addiction and Therapy
9. Febo M, Blum K, Badgaiyan RD, Perez PD, Colon-Perez LM, Thanos PK, Ferris CF, Giordano John, Baron D, Gold Mark S. (2017) Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z. PLoS ONE 12(4): e0174774.
10. Kenneth Blum, Marcelo Febo, Lyle Fried, David Baron, Kristina Dushaj, Mona Li, Zsolt Demetrovics, Rajendra D. Badgaiyan (2017). Pro-Dopamine Regulator - (KB220) to balance brain reward circuitry in Reward Deficiency Syndrome (RDS). Journal of Reward Deficiency Syndrome and Addiction Sciences, 3(1):3-13.
11. Blum, Kenneth; Febo, Marcelo; Gold, Mark S; Baron, David; Dushaj, Kristina; Li, Mona; Demotrovics, Zsolt; Badgaiyan, Rajendra D. (In Press). Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to balance brain reward circuitry in Reward Deficiency Syndrome (RDS). Journal of Reward Deficiency Syndrome.
12. Blum K and Badgaiyan RD. (2017). Report on 2nd International Conference on Addiction Medicine and Reward Deficiency Syndrome (ARDS 2017). Journal of Reward Deficiency Syndrome and Addiction Sciences, 3(1): 1-2.
13. Kenneth Blum, Edward J. Modestino, Roger L. Waite, Eric R. Braverman, Mona Li, Lyle Fried, Marcelo Febo, David Baron, Bruce Steinberg, Thomas McLaughlin, B. William Downs and Rajendra D. Badgaiyan (2017). In a genomic era should we promote dopamine homeostasis” to treat opiate/opioid abuse, instead of blocking brain dopamine function? Medical Research Archives 5(3) March 2017.
14. Kenneth Blum1-9, PhD, DHL, Margaret A. Madigan, RN4, Lyle Fried7, MAC, Eric R. Braverman6, MD, John Giordano5, MAC, DHL, Rajendra D. Badgaiyan9, MD. (2017). Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD). Global Journal of Addiction & Rehabilitation Medicine; 1(2): 555556.
15. Blum Kenneth; Gold, Mark S; Jacobs William; McCall William Vaughn. Vaughn; Febo Marcelo; Baron David; Dushaj Kristina; Demetrovics Zsold; Badgaiyan Rajendra D. (2017). Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause. Frontiers in Bioscience, Landmark 22:1247-1288, March 1
16. Blum Kenneth; Gold Mark S; Demetrovics Zsolt; Archer Trevor; Thanos Peter K; Badgaiyan Rajendra D (2017). Substance Use Disorder a Bio-Directional subset of Reward Deficiency Syndrome. Frontiers in Bioscience, Landmark, 22:1534-1548 (June 2017)
17. Badgaiyan Rajendra D, Blum K (2016). Neuroimaging in psychiatry and neurology: Current status and Future directions. Journal of Neuroimaging in Psychiatry and Neurology. 1(1):1-3.
18. Blum K, Febo M, Badgaiyan Rajendra D. (2016). Fifty years in development of a Glutaminergic-Dopaminergic Optimization complex (KB220) to balance brain reward circuitry in Reward Deficiency Syndrome: A Pictorial. Austin Addiction Science 1(2):1006.
19. Blum, Kenneth; Febo, Marcelo; Fried, Lyle; Li, Mona; Dushaj, Kristina; Braverman, Eric R; McLaughlin, Thomas; Steinberg, Bruce; Badgaiyan Rajendra D (2016) Hypothesizing that Neurophramacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) are indicative of producing “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS). Substance Use and Misuse. 52(4): 535-547.
20. Blum Kenneth; Atzmon G, Baron, David; Badgaiyan Rajendra D (2016). Hypothesizing molecular genetics of the holocaust: Were dopaminergic genes involved or Brain Wash? SOJ Psychology 3(1):1-5.
21. Blum, Kenneth; Whitney, Debra; Fried, Lyle; Febo, Marcelo; Waite, Roger L; Braverman, Eric R; Dushaj, Kristina; Li, Mona; Giordano, John; Demotrovics, Zsolt; Badgaiyan, Rajendra D (2016) Hypothesizing that a pro-dopamine regulator (KB220z liquid variant) can induce “Dopamine Homeostasis” and provide adjunctive detoxification benefits in opiate/opioid dependence. Clin Med Rev and Case Reports, 3(8):125.
22. Blum Kenneth, Febo Marcelo, Dushaj Kristina, Fried Lyle, and Badgaiyan Rajendra D. (2016). Pro-Dopamine Regulation (KB220Z™)” as a Long-Term Therapeutic Modality to Overcome Reduced Resting State Dopamine Tone in Opiate/Opioid Epidemic in America. Psychiatry Investigation. Journal of Systems and Integrative Neuroscience, 2(3)165-168.
23. Blum, K; Febo Marcelo; Fried Lyle; Li, Mona; Dushaj Kristina; Braverman Eric R; Mclaughlin Thomas; Steinberg Bruce; Badgaiyan, RD. (2016) Hypothesizing that Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) are indicative of producing “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS). Substance Use and Misuse 2016 Dec 29: 1-13.
24. Badgaiyan Rajendra D, Sinha Sampada, Sajjad Munawwar, Wack David S. (2015) Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder. PLoS ONE 10(9):e0137326.
25. Blum Kenneth, Badgaiyan Rajendra D, Braverman E, Dushaj Kristina, Li Mona, Thanos Peter K, Demotrovics Zsolt, Febo Marcelo (2016). Hypothesizing that dopamine agonist therapy, should optimize but not hyper-activate the activity of trace amine-associated receptor 1 (TAAR-1) and induce anti-craving of Psychostimulants in the long-Term? Journal of reward Deficiency Syndrome & Addiction Science 2(1):14-21.
26. Blum Kenneth; Downs BW; Dushaj Kristina; Li, Mona; Braverman Eric R; Fried Lyle; Waite, Roger; Demetrovics Zsolt; Downs William B; Barh Debmalya; and Badgaiyan Rajendra D. (2016). The benefits of customized DNA directed nutrition to balance the brain reward circuitry and reduce addictive behaviors. Precision Medicine Journal 1(1); 18-33. PMCID: PMC5210211; NIHMSID: NIHMS807556
27. Blum Kenneth, Febo Marcelo, Badgaiyan Rajendra D, Braverman E, Dushaj Kristina, Li Mona, You S, Demotrovics Zsolt (2016). Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome (RDS): Dopaminergic Key to Homeostasis and Neuroplasticity. Current Pharmaceutical Design 22(46):5837-5854.
28. Blum Kenneth, Gold Mark S, Clark H Westley, Dushaj Kristina, Badgaiyan Rajendra D (2016). Should the United States government repeal restrictions on buprenorphine/naloxone treatment? Substance Use and Misuse.
29. Duquette LL, Mattiace F, Blum K, Waite RL Bolan T, McLaughlin T, Dushaj K Febo M, Badgaiyan Rajendra D (2016). Neurobiology of KB220Z-Glutaminergic–Dopaminergic Optimization Complex [GDOC] as a Liquid Nano: Clinical Activation of Brain in a Highly Functional Clinician Improving Focus, Motivation and Overall Sensory Input Following Chronic Intake. Clinical Medical Reviews and Case Reports, 3(5)3:104
30. Blum Kenneth; Simpatico, Thomas; Febo, Marcelo; Rodgriguez, Chris; Dushaj, Kristina; Li, Mona; Braverman, Eric R; Demetrovics Zsolt; Oscar-Berman, Marlene; Badgaiyan, Rajendra D. (2016) Hypothesizing Music Intervention Enhances Brain Functional Connectivity Involving Dopaminergic Recruitment: Common Neuro-correlates to Abusable Drugs. Molecular Neurobiology. DOI: 10.1007/s12035-016-9934-y. PMID: 27246565.
31. McLaughlin T, Febo Marcelo, Simpatico Thomas, Badgaiyan Rajendra D, Barh Debmalya, Dushaj Kristina, Braverman Eric R, Li Mona, Madigan Margaret A, Blum Kenneth. (2016). KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted Alleviation of Terrifying Lucid Dreams: Can We Infer Neuroplasticity-induced Changes in the Reward Circuit? Journal of Reward Deficiency Syndrome and Addiction Sciences, 2(1):3-13.
32. Beitscher-Campbell Harriet, Blum Kenneth, Febo Marcelo, Madigan Margaret A, Giordano John, Badgaiyan Rajendra D, Braverman Eric R, Dushaj Kristina, Li Mona, Gold Mark S. (2016) Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic. Journal of Behavioral Addictions 5(3): 533-541. PMID: 27502054.
33. Blum Kenneth, Febo Marcelo, Badgaiyan Rajendra D, Demotrovics Zsolt, Simpatico Thomas, Fahike Claudia, Oscar-Burman Marlene, Li Mona, Dushaj Kristina, Gold Mark S (2016). Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape. Current Neuropharmacology 14.
34. Steinberg Bruce, Blum Kenneth, McLaughlin Thomas, Lubar Joel, Febo, Marcelo; Braverman, Eric R, Badgaiyan Rajendra D (2016). Low-resolution electromagnetic tomography (LORETA) of changes brain function provoked by Pro-Dopamine Regulator (KB220Z) in one adult ADHD case. Open Journal of Clinical and Medical Case Reports, 2:11(2016); 1121. PMCID: PMC5012539; NIHMSID: NIHMS813497
35. Blum Kenneth, Hauser Mary, Fratantonio James, Badgaiyan Rajendra D (2015). Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility. Addiction Genetics. 1;2(1):1-5.
36. Blum Kenneth, Badgaiyan Rajendra D, Gold Mark S (2015). Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics. Cureus 7(10):e348.
37. Blum Kenneth, Badgaiyan Rajendra D (2015). Report on the Inaugural Reward Deficiency Syndrome Summit (RDS-1). Journal of Reward Deficiency Syndrome 1(3):97-104.
38. Braverman Eric R, Blum Kenneth, Hussman Karl L, Han David, Dushaj Kristina, Li Mona, Marin Gabriela, Badgaiyan Rajendra D, Smayda Richard, Gold Mark S (2015) Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients. PLoS One 10(8):e0133609.
39. Gold Mark S, Badgaiyan Rajendra D, Blum Kenneth (2015). A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry. Psychiatric Clinics of North America 38(3): 419-462.
40. Miller David, Miller Merlene, Blum Kenneth, Badgaiyan Rajendra D, Febo Marcelo (2015) Addiction Treatment in America: After Money or Aftercare? Journal of Reward Deficiency Syndrome 1(3):97-104.
41. Blum Kenneth, Thanos Peter K, Oscar-Berman Marlene, Febo Marcelo, Baron David, Badgaiyan Rajendra D, Gardner Eliot, Demotrovics Zsolt, Fahlke Claudia, Haberstick Brett C, Dushaj Kristina, Gold Mark S (2015). Dopamine in the brain: Hypothesizing surfeit or deficiency links to reward and addiction. Journal of Reward Deficiency Syndrome 1(3):87-96.
42. Blum Kenneth, Simpatico Thomas, Badgaiyan Rajendra D, Demotrovics Zsolt, Fratantonio James, Agan Gozde, Febo Marcelo, Gold Mark S (2015). Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms. J Reward Deficiency Syndrome 1(2)75-80.
43. Blum Kenneth, Badgaiyan Rajendra D, Gold Mark S (2015). “Personalized addiction medicine” may take us to promised land: Coupling neurogenetic risk and nutrigenomic dopaminergic activation. Jacobs Journal of Molecular and Translational Medicine, 1(1):001. 2015 Mar 3.
44. Blum Kenneth, Thanos Peter K, Badgaiyan Rajendra D, Febo Marcelo, Oscar-Berman Marlene, Fratantonio James, Demotrovics Zsolt, Gold Mark S (2015). Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? Expert Opinion on Biological Therapy. 14:1-13.
45. Badgaiyan Rajendra D, Sinha Sampada, Blum Kenneth (2015). Do We Really Need to Continue Pharmacotherapy for Opioid Use Disorder (OUD) Indefinitely? Journal of Reward Deficiency Syndrome 1(1): 16-19.
46. Blum Kenneth, Braverman Eric R, Waite Roger L, Archer Trevor, Thanos Peter K, Badgaiyan Rajendra D, Febo Marcelo, Dushaj Kristina, Li Mona, Gold Mark S (2015). Neuroquantum Theories of Psychiatric Genetics: Can Physical Forces Induce Epigenetic Influence on Future Genomes? NeuroQuantology, 13(1) 90-113.
47. Blum Kenneth, Badgaiyan Rajendra D (2015) Reward Deficiency Syndrome (RDS): Entering the Genomics and Neuroscience Era of Addiction Medicine. Journal of Reward Deficiency Syndrome, 1(1):1-2.
48. Blum Kenneth, Badgaiyan Rajendra D, Agan Gozde, Fratantonio James, Simpatico Thomas, Febo Marcelo, Haberstick Brett C, Smolen Andrew, Gold Mark S (2015). Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction. Journal of Reward Deficiency Syndrome 1(1): 65-68.
49. Blum Kenneth, Badgaiyan Rajendra D, Demotrovics Zsolt, Fratantonio James, Agan Gozde, Febo Marcelo (2015). Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? Clinical Medical Reviews and Case Reports 2:018 PMID: 26225358; PMCID: PMC4516390. 2015 Feb 28.
50. Schoenthaler Stephen J, Blum Kenneth, Braverman Eric R, Giordano John, Thompson Benjamin, Oscar-Berman Marlene, Badgaiyan Rajendra D, Madigan Margaret A, Dushaj Kristina, Li Mona, Demotrovics Zsolt, Waite Roger L, Gold Mark S (2015). NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity. Journal of Reward Deficiency Syndrome, 1(1)36-45.
51. Blum Kenneth, Thompson Benjamin, Demotrovics Zsolt, Femino John, Giordano John, Oscar-Berman Marlene, Teitelbaum Scott, Smith David E, Roy A Kennison 3rd, Agan Gozde, Fratantonio James, Badgaiyan Rajendra D, Gold Mark S (2015). The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery. Journal of Reward Deficiency Syndrome, 1(1)46-64.
52. Blum Kenneth, Badgaiyan Rajendra D, Angres Daniel H, Gold Mark S (2015). Should We Embrace Vaccines for Treating Substance-Related Disorder, A Subset of Reward Deficiency Syndrome (RDS)? Journal of Reward Deficiency Syndrome. 1(1):3-5.
53. Blum Kenneth, Febo Marcelo, Demotrovics Zsolt, Badgaiyan Rajendra D (2015). Embracing reward deficiency syndrome (RDS) solution system: A genomic thrust. International Archives of Addiction Research and Medicine 1:001e. 2015 Feb 21.
54. Blum Kenneth, Febo Marcelo, Smith David E, Roy A Kennison 3rd, Demotrovics Zsolt, Cronje Frans J, Femino John, Agan Gozde, Fratantonio James, Pandey Subhash C, Badgaiyan Rajendra D, Gold Mark S (2015). Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulation. Journal of Child and Adolescent Psychopharmacology. 25(4):286-292.
55. Blum Kenneth, Hauser Mary, Agan Gozde, Giordano John, Fratantonio James, Badgaiyan Rajendra D, Febo Marcelo (2015) Understanding the importance of dopaminergic deficit in Reward Deficiency Syndrome (RDS): redeeming joy overcoming “darkness” in recovery. Psychology, 6(4):435-439.
56. Campbell HB, Blum Kenneth, Febo Marcelo, Madigan Margaret A, Giordano John, Badgaiyan Rajendra D, Braverman Eric R, Dushaj Kristina, Li Mona, Gold Mark S (In Press). Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic. Journal of Behavioral Addictions.
57. Blum Kenneth, Febo Marcelo, Fahlke Claudia, Archer Trevor, Berggren U, Demotrovics Zsolt, Dushaj Kristina, Badgaiyan Rajendra D (2015). Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic Modality. Clinical Medical Reviews and Case Reports 2(8):076. PMID: 26900600; PMCID: PMC4760695. 2015 Dec 17.
58. Blum Kenneth, Badgaiyan Rajendra D, Agan Gozde, Fratantonio James, Gold Mark S (2014) Reward Deficiency System (RDS): Is there a Solution? Journal of Alcoholism and Drug Dependence 2:177.
59. Blum Kenneth, Badgaiyan Rajendra D, Gold Mark S (2014). Reward Deficiency Solution Syndrome (RDS): A tale of three Scientists. Journal of Addiction Medicine and Therapeutic Science. 1(1):104. 2014 Nov 17.
60. Badgaiyan Rajendra D, Weise S, Wack David S, Vidal Melo Marcos F (2014). Attenuation of regional cerebral blood flow during memory processing after coronary artery bypass surgery. Anesthesia and Analgesia 119(3):550-553.
61. Blum Kenneth, Oscar-Berman Marlene, Badgaiyan Rajendra D, Braverman Eric R, Gold Mark S (2014) Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function. Psychology (Irvine), 5 (4):282-288.
62. Blum Kenneth, Oscar-Berman Marlene, Badgaiyan Rajendra D, Khurshid Khurshid A, Gold, Mark S (2014) Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS). Journal of Sleep Disorders and Therapy.
63. Blum Kenneth, Oscar-Berman Marlene, Badgaiyan Rajendra D, Palomo, Thomas, Gold Mark S (2014) Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. Medical Hypothesis. 82(5):606-14.
64. Blum Kenneth, Badgaiyan Rajendra D (2013). Addiction Research and Therapy in the 21st Century: Providing a Forum for Evidence -Based Addiction Medicine. Journal of Addiction Research and Therapy 4:4 e-117.
65. Blum Kenneth, Oscar-Berman Marlene, DiNubile Nicholas, Giordano John, Braverman Eric R, Truesdell Courtney E, Barh Debmalya, Badgaiyan Rajendra D (2013). Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence. Journal of Addiction Research and Therapy 4:163:1000163.
66. Badgaiyan Rajendra D (2013). Detection of dopamine neurotransmission in "real time". Frontiers in Neuroscience. 7:125.
67. Badgaiyan Rajendra D (2012) Nonconscious processing and a novel target for schizophrenia research. Open Journal of Psychiatry 2:335-339.
68. Badgaiyan Rajendra D (2012) Manipulation of the extrastriate frontal loop can resolve visual disability in blindsight patients. Medical Hypotheses 79:767-769 PMID: 22986005; PMCID: PMC3507356. 2012 Sep 15.
69. Badgaiyan Rajendra D (2012) Nonconscious perception, conscious awareness and attention. Consciousness and Cognition 21:584-586. PMID: 22285425; PMCID: PMC4107354. 2012 Jan 30.
70. Badgaiyan Rajendra D (2012) A Novel Perspective on Dopaminergic Processing of Human Addiction. Journal of Alcoholism and Drug Dependence 1:1-3.
71. Badgaiyan Rajendra D (2011) Neurotransmitter Imaging: Current Status and Challenges (Editorial) Current Medical Imaging Reviews. 7:96-97.
72. Badgaiyan Rajendra D (2011) Neurotransmitter imaging: Basic concepts and future perspectives. Current Medical Imaging Reviews. 7:98-103
73. Badgaiyan Rajendra D, and Wack David (2011) Evidence of dopaminergic processing of executive inhibition. PLoS ONE 6(12): e28075.
74. Wack David, and Badgaiyan Rajendra D (2011) Complex singular value decomposition based noise reduction of dynamic PET images. Current Medical Imaging Reviews.7:113-117.
75. Badgaiyan Rajendra D. (2010) Dopamine is released in the striatum during human emotional processing. NeuroReport. 21:1172-6. PMID: 21057339; PMCID: PMC2997433. 2010 Dec 29.
76. Badgaiyan Rajendra D (2009) Theory of mind and schizophrenia. Consciousness and Cognition 18:320-322 PMID: 19071031; PMCID: PMC4605560. 2008 Dec 13.
77. Badgaiyan Rajendra D, Fischman Alan J, Alpert Nathaniel M (2009) Dopamine release during human emotional processing. NeuroImage 47: 2041-2045 PMID: 19524047; PMCID: PMC2740985. 2009 Jun 11.
78. Badgaiyan Rajendra D, Fischman Alan J, Alpert Nathaniel M (2008) Explicit motor memory activates the striatal dopamine system. NeuroReport, 19:409-412 PMID: 18287937 . 2008 Mar 5.
79. Badgaiyan Rajendra D, Fischman Alan J, and Alpert Nathaniel M (2007) Striatal dopamine release in sequential learning. NeuroImage, 38:549-556. PMID: 17888684; PMCID: PMC2077859. 2007 Aug 15.
80. Fischman Alan J and Badgaiyan Rajendra D (2007) Functional imaging of neurotransmission. Current Medical Imaging Reviews.3(4):220-224.
81. Fischman Alan J and Badgaiyan Rajendra D (2006) Cortical activations, psychiatric symptoms, and climacteric women (Editorial). Menopause. 13:1-3 PMID: 17077750 . 2006 Nov/Dec.
82. Badgaiyan Rajendra D (2006) Cortical activation elicited by unrecognized stimuli. Behavioral and Brain Functions.2:17.
83. Sharma Hari S, Wiklund L, Badgaiyan Rajendra D, Mohanty S and Alm Per (2006) Intracerebral administration of neuronal nitric oxide synthase antiserum attenuates traumatic brain injury-induced blood-brain barrier permeability, brain edema formation, and sensory motor disturbances in the rat. Acta Neurochir. 2006; 96:288-94. PMID: 16671473.
84. Badgaiyan Rajendra D (2005) Conscious awareness and the brain processing. Elements, 3:8-12 PMID: 21188282; PMCID: PMC3007594. 2010 Dec 22.
85. Badgaiyan Rajendra D (2005) Conscious awareness of retrieval: An exploration of the cortical connectivity. International Journal of Psychophysiology, 55:257-262 PMID: 15649556. 2004 Sep 15.
86. Sharma Hari S, Badgaiyan Rajendra D, Alm Per, Mohanty S and Wiklund Lars (2005) Neuroprotective effects of nitric oxide synthase inhibitors in spinal cord injury-induced pathophysiology and motor functions: an experimental study in the rat. Annals of New York Academy of Sciences 1053:422-34. PMID: 16179549. 2008 Jun 28.
87. Badgaiyan Rajendra D, Fischman Alan J and Alpert Nathaniel M. (2003) Striatal dopamine release during unrewarded motor task in human volunteers. NeuroReport, 14:1421-1424. PMID: 12960756.
88. Alpert Nathaniel M, Badgaiyan Rajendra D, Livni Elijahu, and Fischman Alan J (2003) A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. NeuroImage, 19:1049-1060. PMID: 12880831.
89. Badgaiyan Rajendra D, Schacter Daniel L and Alpert Nathaniel M (2003) Priming of new associations: A PET study. NeuroReport. 14:2475-2479 PMID: 14663213.
90. Winkler T, Sharma Hari S, Stalberg E, Badgaiyan Rajendra D, Gordh T and Westman J. (2003) An l-type calcium channel blocker, nimodipine influences trauma induced cord conduction and axonal injury in the rat. Acta Naurochir, 86:425-432. PMID: 14753480.
91. Badgaiyan Rajendra D (2002) Nonconscious processing, anterior cingulate, and catatonia. Behavioral and Brain Sciences. 25:578-579.
92. Badgaiyan Rajendra D, Schacter Daniel L and Alpert Nathaniel M (2002) Retrieval of relational information: a role for the left inferior prefrontal cortex. NeuroImage, 17:393-400. PMID: 12482092.
93. Winkler T, Sharma Hari S, Gurdh T, Badgaiyan Rajendra D, Stalberg E and Westman J. (2002) Topical application of dynorphin A (1-17) antiserum attenuates trauma-induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury. Amino Acids, 23:273-281. PMID: 12373547.
94. Badgaiyan Rajendra D, Schacter Daniel L and Alpert Nathaniel M. (2001) Priming within and across modalities: Exploring the nature of rCBF increases and decreases. NeuroImage, 13:272-282. PMID: 11162268.
95. Schacter Daniel L and Badgaiyan Rajendra D (2001) Neuroimaging of priming: New perspectives on implicit and explicit memory. Current Directions in Psychological Science, 10:1-4.
96. Winkler T, Sharma Hari S, Stalberg E and Badgaiyan Rajendra D (2001) Neurotrophic Factors Attenuate Alterations in Spinal Cord Evoked Potentials and Edema Formation Following Trauma to the Rat Spinal Cord. Acta Neurochirurgica; 76:S291-S296. PMID: 11450028.
97. Badgaiyan Rajendra D (2000) Neuroanatomical organization of perceptual memory: An fMRI study of picture priming. Human Brain Mapping, 10:197-203. PAPER HIGHLIGHTED IN THE JOURNAL. PMID: 10949057.
98. Badgaiyan Rajendra D (2000) Executive control, willed actions, and nonconscious processing. Human Brain Mapping, 9:38-41. PMID: 10643728. 2000 Feb 16.
99. Casey BJ, Thomas Kathleen M, Welsh Tomihisa F, Badgaiyan Rajendra D, Eccard Clayton H, Jenning JR and Crone Eveline A (2000) Dissociation of response conflict, attentional selection, and expectancy with functional magnetic resonance imaging. Proceedings of the National Academy of Sciences USA, 97:8728-8733. PMID: 10900023; PMCID: PMC27016. 2000 Jul 18.
100. Winkler T., Sharma Hari S, Stalberg E, Badgaiyan Rajendra D, Westman J and Nyberg F (2000) Growth hormone attenuates alterations in spinal cord evoked potentials and cell injury following trauma to the rat spinal cord. An experimental study using topical application of rat growth hormone. Amino Acids, 19:363-371. PMID: 11026507.
101. Winkler T, Sharma Hari S, Stalberg E and Badgaiyan Rajendra D (2000) Neurotrophic factors attenuate alterations in spinal cord evoked potentials and edema formation following trauma to the rat spinal cord. Acta Neurochirurgica, 76:291-296. PMID: 11450028.
102. Badgaiyan Rajendra D, Schacter Daniel L and Alpert Nathaniel M (1999) Auditory priming within and across modalities: evidence from positron emission tomography. Journal of Cognitive Neuroscience, 11:337-348. PAPER HIGHLIGHTED ON THE JOURNAL COVER. PMID: 10471844 . 1999 Jul.
103. Schacter Daniel L, Badgaiyan Rajendra D and Alpert Nathaniel M (1999) Visual word stem completion priming within and across modalities: A pet study. NeuroReport, 10:2061-2065. PMID: 10424675. 1999 Jul 13.
104. Badgaiyan Rajendra D and Posner Michael I (1998) Mapping the cingulate cortex in response selection and monitoring. NeuroImage, 7:255-260. PMID: 9597666. 1998 Apr.
105. Winkler T, Sharma Hari S, Stalberg E, Badgaiyan Rajendra D, Alm Per and Westman J (1998) Spinal cord evoked potentials and edema in the pathophysiology of rat spinal cord injury. Amino Acids, 14:131-139. PMID: 9871452.
106. Badgaiyan Rajendra D and Posner Michael I (1997) Time course of cortical activations in implicit and explicit recall. Journal of Neuroscience, 17:4904-4913. PMID: 9169548. 1997 Jun 15.
107. Badgaiyan Rajendra D and Posner Michael I (1996) Priming reduces input activity in right posterior cortex during stem completion. NeuroReport, 7:2975-2978. PMID: 9116222. 1996 Nov 25.
108. Badgaiyan Rajendra D and Mandal Maloy B. (1995) Centrally infused anions alter body temperature in conscious rats. Brain Research Bulletin 38:331-336. PMID: 8535855.
109. Misra CP, Gupta S, Tiwari IC and Badgaiyan Rajendra D (1993) Dietary pattern of lactating women in an urban community. Indian Journal of Nutr. Diet, 30:180-183.
110. Mandal Maloy B and Badgaiyan Rajendra D (1991) Dipsogenic and feeding influences of intraventricularly infused anionic choline solutions. Physiology and Behavior, 50:783-787. PMID: 1775554. 1991 Oct.
111. Badgaiyan Rajendra D and Mandal Maloy B (1990) Alterations of ventricular pH alter Water intake and food consumption in rats. Physiology and Behavior, 47:489-492. PMID: 2359758. 1990 Mar.
112. Badgaiyan Rajendra D (1989) Third ventricular chloride infusion enhances drinking in water deprived rats. Physiology and Behavior, 45:951-954. PMID: 2780880. 1989 May.
113. Reghunandanan Vallath, Badgaiyan Rajendra D, Marya RK, Reghunandanan R and Maini BK (1989) Lithium chloride SCN injection alters the circadian rhythm of food intake. Chronobiology International, 6:123-129. PMID: 2545362.
114. Badgaiyan Rajendra D (1987) Intracerebroventricular chloride infusion enhances water intake in rats. Physiology and Behavior 41:605-608. PMID: 3441530.
115. Reghunandanan Vallath, Badgaiyan Rajendra D, Marya RK, and Maini BK (1987) Suprachiasmatic injection of a vasopressin antagonist modifies the circadian rhythm of food intake. Behavioral and Neural Biology, 48:344-351. PMID: 3689283. 1987 Nov.
116. Badgaiyan Rajendra D and Bhargava RP (1986) Influence of intracerebroventricularly infused anions on feeding response. Physiology and Behavior, 38:761-764. PMID: 3823193.
117. Bhargava RP, Datta S and Badgaiya RD (1985) A simple technique to stop hiccups. Indian Journal of Physiology and Pharmacology, 29:57-58. PMID: 4055019. 1985 Jan-Mar.
118. Non-refereed Journals
119. Badgaiyan Rajendra D. (1990) The psychophysiology of behavior. BHU Newsletter. 4:24-26.

Book Chapters

1. Badgaiyan Rajendra D (2014). Imaging Dopamine Neurotransmission in Live Human Brain. Progress in Brain Research: Dopamine (Chapter 7). Eds: Diana M, Chiara GD, Spano P. Elsevier, 211: 167-184 DOI: 10.1016/B978-0-444-63425-2.00007-6.
2. Fischman Alan J Badgaiyan Rajendra D (2006) Neurotransmitter Imaging. In: Charron M, ed. Pediatric PET. New York: Springer; pp 385-403.
3. Posner Michael I and Badgaiyan Rajendra D (1998) Attention and Neural Networks. In: Fundamentals of Neural Network Modeling for Neuropsychology. Eds. Parks, W.R. and Levine, D.S. MIT Press, pp 61-76.
4. Blum Kenneth; Febo Marcelo; Braverman Eric R; Li, Mona; Fried Lyle; Waite, Roger Downs; Demetrovics Zsolt; Downs William B; Barh Debmalya; Steinberg Bruce; McLaughlin Thomas; and Badgaiyan Rajendra D. (2016). Customized DNA (Precision Medicine) directed nutrition to balance the brain reward circuitry and reduce addictive behaviors. Precision Medicine: Prediction, Prevention and Personalization. Ed: Debmalya Barh. CRC Press (Taylor and Francis Group) New Delhi, India.
5. Badgaiyan Rajendra D (1992) Central anionic influences on dipsogenic response. In: Advances in Physiological Sciences. Ed. S.K.Manchanda, W.Selvamurthy and V.Mohan Kumar, Macmillan, New Delhi, pp 700-706.
6. Bhargava RP, Rao SV, Badgaiyan Rajendra D (1980). Translated into Hindi: Text Book of Physiology. Authors, S. Subramaniam, and M. Kutty, 1979. Central Hindi Directorate, New Delhi, 1980.
7. Kenneth Blum, Peter K Thanos, Gene Jack Wang, Marcelo Febo, Zsolt Demetrovics, Mark Gold, Edward Justin Modestino, Eric R. Braverman, David Baron, Rajendra D. Badgaiyan (Under review). The food & drug addiction epidemic: targeting dopamine homeostasis. Current Pharmaceutical Design
8. Stephen J Schoenthaler, Kenneth Blum, Lyle Fried, Marlene Oscar-Berman, John Giordano, Edward J. Modestino, Rajendra Badgaiyan. (In Review). The effects of residential dual diagnosis treatment on alcohol abuse. Journal of Systems and Integrative Neuroscience
9. Kenneth Blum, Rajendra D Badgaiyan,, Georgia M. Dunston, David Baron, Edward J. Modestino, Thomas McLaughlin, Bruce Steinberg, Mark S. Gold, Marjorie C Gondré-Lewis (Under review) Hypothesizing DRD2 TaqA1 Allele Magnifies the Risk of Alzheimer’s in Aging African Americans. Molecular Neurobiology
10. Kenneth Blum, David Han, David E. Smith, Edward J. Modestino, Scott Saunders, A. Kennison. Roy, III, W. Jacobs, Daryl. Inaba, Rajendra D. Badgaiyan, David Baron, Marlene Oscar-Berman, Mary Hauser, Mark S. Gold (Under Review) Comprehensive Analysis of Reported Drugs (CARD™) in Urine of Buprenorphine/Naloxone Patients for Compliance and Illicit Opioid Abstinence
11. Mark S. Gold, Kenneth Blum, Marcelo Febo, David Baron, Edward Modestino, Igor Elman, and Rajendra D. Badgaiyan (Under Review). Molecular Aspects of Dopamine in Anhedonia Linked to Reward Deficiency Syndrome (RDS) and Anti- Reward Systems. Frontiers in Biosciences
12. Kenneth Blum, Mark S. Gold, Peter K. Thanos, Marcelo Febo, David Baron, Edward J Modestino, Rajendra D. Badgaiyan (Under Review). Buprenorphine and Naloxone combinations and Dopamine. Substance Use Misuse
13. Blum Kenneth, Elman Igor, Borsook David, Badgaiyan Rajendra D. (Under Review). Paradoxically Combining Mu opiate Receptor Blocking (Naltrexone) with Pro Dopamine Regulation (KB220z) May Provide Long-Term Reward Deficiency Benefits: Hypothesizing negative feedback MU Opiate receptor proliferation.
14. Kenneth Blum, Brett C. Haberstick , Andrew Smolen , David Han , Marlene Oscar-Berman, David E. Smith, Thomas Simpatico, Joan Borsten, Elizabeth Winchel, John Giordano, Scott Jones, Eric R. Braverman, Kristina Dushaj, Mona Li, Marcelo Febo, Mary Hauser, John Femino, Albert Villapiano, Stephen Butler, A. Kennison Roy, Holly Cook, Lee McCormick , Carolee Lindsey, Thomas McLaughlin, Adi Jaffe, Debmayla Barh, Bruce Steinberg, Zsolt Demetrovics, David D. Baron, Panayotis (Peter) K Thanos, Margaret A. Madigan, David Siwicki, Daryl Inaba, Pauline Gee, Lyle Fried, Mark S. Gold, Rajendra Badgaiyan (Under Review). Genetic Addiction Risk Score (GARSTM) Predicts Addiction Severity Index –MV Alcohol and Drug – Risk Scores in a Multi-Center Study.
15. Blum Kenneth; Han David; Smith, David E; Saunders, Scott; Roy III A. Kennison; Jacobs W; Inaba Daryl; Badgaiyan Rajendra D; Baron David; Oscar-Berman Merlene; Gold Mark S. (Under Review). Large Cohort Systematic Observational Analysis of Both Compliance and Illicit Opioid Abstinence as a Function of Buprenorphine/naloxone Based Addiction Programs: Statistical evaluation of data from the Comprehensive Analysis of Reported Drugs (CARD™). Substance Use and Misuse Invited Special Issue on MATS.
16. Blum Kenneth, McLaughlin Thomas, Oscar-Berman Marlene, Badgaiyan Rajendra D. Is major depression a subtype of Reward Deficiency Syndrome (RDS): Illuminating darkness. Austin Psychiatry.
17. Kenneth Blum, PhD1-7* Gene-Jack Wang, MD8 Peter K. Thanos, PhD9 David Baron, DO2 Eric R. Braverman, MD3 Rajendra D. Badgaiyan, MD10 Marcelo Febo, PhD1 and Mark S. Gold, MD. Targeting brain dopamine as a preventive strategy for food and drug addiction. Lancet Public Health..
18. Kenneth Blum1-8,10, Mark S. Gold1,14, Peter K. Thanos,11 Marcelo Febo1, Mary Hauser2, David Siwicki2, Zsolt Demetrovics7, 8Kristina Dushaj, Abraham Kovoor12, David Baron4, David E. Smith13, Kennison Roy lll14 and Rajendra D. Badgaiyan (under review) Hypothesizing that Genetic Testing Should Be Mandated in the Treatment of Non -Cancerous Pain with Opioids: Neurochemical Interactions between Cannabinergic-Opioidergic-Glutaminergic–Dopaminergic Systems. Frontiers in Bioscience. .
19. Blum Kenneth, Gold Mark S, Febo Marcelo, Siwicki David, Kristina Dushaj Kristina, and Badgaiyan Rajendra D. Should genetic testing be mandated in the treatment of acute pain with opioids: Neurochemical interactions between cannabinoid-glutaminergic-dopaminergic systems. Journal of Drug Abuse and Addiction.
20. Badgaiyan Rajendra D, and Fischman Alan J. Attenuated dopamine release during emotional processing in PTSD.
21. Badgaiyan Rajendra D, and Wack David. Dopamine neurotransmission during nonconscious processing.
22. Badgaiyan Rajendra D. Cognitive neuroscience of conscious awareness.
23. Schoenthaler Steven J, Blum Kenneth, Badgaiyan Rajendra D, Oscar-Berman Marlene, Giordano John, Agan Gozde, Simpatico Thomas (Under Review). The effects of residential dual diagnosis treatment on alcohol abuse. American Journal of Addictions.
24. Febo Marcelo, Blum Kenneth, Badgaiyan Rajendra D, Perez PD, Colon-perez LM, Thanos Peter K, Ferris CF, Kulkarni P, Femino John, Giordano John, Fratantonio James, Baron D, Gold Mark S (under review). KB220Z complex enhances resting state brain reward circuit functional connectivity (rsfMRI) and connectivity volume in naive rodents: Are we targeting “Dopamine Homeostasis” and neuroplasticity? eLife.
25. Blum, Kenneth; Febo, Marcelo; Gold, Mark; Baron, David; Dushaj, Kristina; Li, Mona; Braverman, Eric R; Zsolt, Demotrovicz; Badgaiyan Rajendra D (Under review) Glutaminergic–Dopaminergic Optimization Complex (KB220) to balance brain reward circuitry in Reward Deficiency Syndrome (RD) European Journal of Neuroscience.
26. Blum K, Gold Mark S, Elman Igor, Borsook David, Febo Marcelo, Oscar–Berman Marlene,1 Demetrovics Zsolt, McLaughlin Thomas, Thanos Peter K, Baron David, Badgaiyan Rajendra D. Are We Illuminating Darkness by the Inclusion of Major Depression, as a Subtype of Reward Deficiency Syndrome (RDS)? Progress in Neurobiology.